Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
The MEG business of Elekta has been acquired by York Instruments Ltd
We advised Elekta AB on the sale of MEGIN, its MEG business, to York Instruments Ltd. Financial details have not been disclosed.
Learn moreC.D.C. Complete tandzorg has sold a stake to G Square Healthcare Pte. Equity
G Square Healthcare Private Equity (G Square) has invested in C.D.C. Complete tandzorg (CDC). The partnership will enable CDC to expand its complex dental care service offering to other regions in the Netherlands by opening new practices. Financial details have not been made public.
Learn moreA-Med Medical Supply Division has been acquired by Byram Healthcare Centers, Inc.
A-Med Health Care (A-Med) has sold its Medical Supplies Division to Byram Healthcare Centers, Inc. (Byram), a wholly owned subsidiary of Mediq NV. The acquisition represents an EBITDA multiple of approximately 7.5x, excluding synergies.
Learn more
Ruben Hoefnagels
Founder and CEO, Tandarts Today
Read more
Challenges ahead after a positive start to 2022
MONTHLY DEAL ACTIVITY: 2022 has got off to a good start for Oaklins with 36 closed transactions of which 34 were M&A deals and two were fundraising deals. On top of that, we saw a big increase in cross-border deal activity. However, due to recent events, dealmaking in 2022 is suddenly looking a lot more uncertain.
Learn more
Talk to our local specialists
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital